Q&A: What can $250 million achieve? Chief of new cancer immunotherapy institute explains
Jeffrey Bluestone says collaboration, funding to take risks will extend therapy’s reach
Cancer topic
-
-
Brazil president signs law legalizing renegade cancer pill
Scientists decry decision grounded in “pseudoscience” -
-
Scientific advisers tapped to guide Biden’s cancer moonshot
Panel of 28 scientists, patient advocates, industry leaders will develop research plan -
GSK to make cancer drugs more accessible in poor countries
Retiring CEO says the new approach combines societal needs with profit motive -
Cells can do the twist, but sometimes their nuclei burst
Crawling through tight spaces tears the membrane around the cell nucleus -
Nano-balls filled with poison wipe out metastatic cancer in mice
Polymers laden with chemotherapy drugs assemble at tumor cells and slip past their defenses -
Vitamin C kills tumor cells with hard-to-treat mutation
Study rejuvenates hopes that vitamin C can treat some common cancers
- « first
- ‹ previous
- 1
- 2
- 3
- 4
